Priavoid GmbH
Düsseldorf, Germany
|
Priavoid GmbH is a drug discovery company that develops novel all-d-peptide drug candidates for the treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, ALS, tauopathies, and Huntington’s disease. The most advanced candidate is PRI-002 for Alzheimer’s disease.